Drug class in one race
5-HT2A/2C receptor drugs for Parkinson's Disease
2 tracked 5-HT2A/2C receptor drugs in the Parkinson's Disease race. The class explanation lives on the 5-HT2A/2C receptor page; the full indication pipeline across every mechanism is on the Parkinson's Disease page.
1 Phase 31 Phase 1
Head-to-head evidence: LY03017 vs Pimavanserin